Thomas Stephen Basil
Insider CIK 2027962 · CLYM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLYM Climb Bio, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 100,000 | $13.67 | $1.37M | 467,969 | SEC↗ |
| CLYM Climb Bio, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 100,000 | $13.67 | $1.37M | 467,969 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLYM Climb Bio, Inc. | S Sale | 2026-02-26 | 2026-02-27 | 16,313 | $7.01 | $114.4K | 154,657 | SEC↗ |
| CLYM Climb Bio, Inc. | S Sale | 2026-02-25 | 2026-02-27 | 33,687 | $7.00 | $235.8K | 170,970 | SEC↗ |
| CLYM Climb Bio, Inc. | S Sale | 2026-02-13 | 2026-02-17 | 10,000 | $5.81 | $58.1K | 204,657 | SEC↗ |
| CLYM Climb Bio, Inc. | S Sale | 2026-02-12 | 2026-02-17 | 90,000 | $5.23 | $470.7K | 214,657 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award | 2025-08-07 | 2025-08-11 | 100,375 | — | $0 | 304,657 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2025-06-27 | 2025-07-01 | 25,094 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2025-06-27 | 2025-07-01 | 25,094 | — | $0 | 204,282 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2025-03-27 | 2025-03-27 | 25,093 | — | $0 | 25,094 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2025-03-27 | 2025-03-27 | 25,093 | — | $0 | 179,188 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2025-01-01 | 2025-01-03 | 50,188 | — | $0 | 50,187 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2025-01-01 | 2025-01-03 | 50,188 | — | $0 | 154,095 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2024-06-27 | 2024-06-27 | 100,375 | — | $0 | 100,375 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award | 2024-06-27 | 2024-06-27 | 103,907 | — | $0 | 103,907 | SEC↗ |